A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

We prospectively evaluated the bone changes associated with proteasome inhibition using single agent bortezomib in relapsed or refractory myeloma patients. Ten patients received bortezomib 1.3 mg/m(2) per days 1, 4, 8 and 11 for three 21-day cycles, and 6 patients received 1 mg/m(2) per day with the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zangari, Maurizio, Yaccoby, Shmuel, Pappas, Lisa, Cavallo, Federica, Kumar, Naveen Sanath, Ranganathan, Subramanian, Suva, Larry J., Gruenwald, J. Michael, Kern, Steven, Zhan, Fenghuang, Esseltine, Dixie, Tricot, Guido
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ferrata Storti Foundation 2011
Schlagworte:
Brief Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031705/
https://ncbi.nlm.nih.gov/pubmed/20952514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.031302
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge